Home
Search
Search Only:

Search Keyword clinical

Total: 50 results found.

Page 1 of 3
... is one of the reasons that CIHR has heavily invested in Clinical Autoimmunity research, in an effort to understand the mechanisms that cause autoimmune disorders and develop more effective treatments ...
Nova Scotia's premier has added his voice to a growing chorus of support for a national clinical trial for a controversial treatment for multiple sclerosis. Darrell Dexter's comments in favour of ...
... cases. The overall global PML rate is about 0.80 per 1,000 patients, the company said, which falls within the 1-in-1,000 rate previously seen in clinical trials and implied on the drug's label. As ...
Quebec's health minister says he's ready to join other provinces in a national clinical trial of a controversial treatment for multiple sclerosis. Yves Bolduc says he's very open to Quebec collaborating ...
Manitoba Health Minister Theresa Oswald on Monday sought support from other Canadian leaders to launch a nationwide clinical trial to test the efficacy of a controversial multiple sclerosis treatment which ...
Abstract Human mesenchymal stem cells (hMSCs) are being considered for clinical trials of multiple sclerosis (MS). We examined the effects of adult bone marrow-derived hMSCs on responses of primary human ...
... (MS) has been demonstrated; however, its role in modulating MS clinical course has been little studied. We investigated whether higher levels of serum 25-hydroxyvitamin D (25-OH-D) were associated with ...
... Zwozdesky is pulling together a working group of about a dozen people to examine the issue, he said Thursday. The group will look into whether the province should pay for clinical studies of the so-called ...
... Methods: Two (2) coronal cadaver brain slices from patients clinically diagnosed with multiple sclerosis underwent magnetic resonance imaging (MRI), specifically SWI to image iron content. To confirm the ...
... of incoordination in MS subjects. Methods: Eight subjects with clinically defined MS performed planar reaching movements while grasping the handle of a robotic manipulandum, which generated forces that ...
Saskatchewan is ready to help pay for clinical trials of the so-called liberation treatment for multiple sclerosis sufferers, despite a lack of scientific evidence that it might work, says Premier Brad ...
Abstract Objectives: Prediction of long term clinical outcome in patients with primary progressive multiple sclerosis (PPMS) using imaging has important clinical implications, but remains challenging. ...
OBJECTIVE: To describe a case of successful clinical management of natalizumab-associated progressive multifocal leukoencephalopathy (PML) and immune reconstitution syndrome (IRIS) in a patient with multiple ...
... Medicine for Sale?? It was prompted by a clinical trial of an antidepressant called Serzone that was published in the same issue of the Journal. The authors of that paper had so many financial ties to ...
... from clinical studies, there are papers showing that microbes affect MS," Mazmanian says. "For example, the disease gets worse after viral infections, and bacterial infections cause an increase in MS symptoms." On ...
... had no clinical justification. The framework includes a set of national outcome goals which patients and the public can use to judge the overall performance of the NHS and hold the Government to account ...
... the company said, which falls within the 1-in-1,000 rate previously seen in clinical trials and implied on the drug's label. Of the total cases, 22 were in the U.S., 32 were in the European Union and ...
... these oral drugs are set to become the leading MS therapies by 2014. Currently Gilenia has the advantage of being recommended as a first-line therapy by the FDA advisory panel supported by robust clinical ...
... outcome was the rate of change of partial (central) cerebral volume over 24 months. All patients who were randomly assigned were included in the primary analysis. This trial is registered with ClinicalTrials.gov, ...
... FTY720 clinical trials who discontinued therapy after prolonged use (>1-5years), and examined histological features of a mediastinal lymph node obtained from a lymphopenic FTY720 patient. Although three ...
«StartPrev123NextEnd»